Literature DB >> 1671004

Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4.

J M Doutrelepont1, M Moser, O Leo, D Abramowicz, M L Vanderhaegen, J Urbain, M Goldman.   

Abstract

Intravenous injection of 2 x 10(8) DBA/2 spleen cells into adult intact (C57BL/6 x DBA/2) F1 mice results in a stimulatory graft-versus-host reaction (GVHR) linked to the recognition by donor CD4+ T cells of Ia alloantigens on host B cells. In the experiments presented here, we found that this GVHR is associated with a major increase in IgE serum levels which was already present 7 days after the cell transfer. At 6 weeks, mean IgE levels were more than 200-fold above the control values. Host B cells were responsible for the hypersecretion of IgE in stimulatory GVHR since it was also observed when the DBA/2 donor inoculum was depleted of B cells but not when the F1 recipients were irradiated. The induction of IgE secretion required donor CD4+ T cells as treatment of the donor inoculum with lytic anti-CD4 monoclonal antibody (MoAb) completely prevented the occurrence of the hyper IgE whereas depletion of CD8+ cells had no influence on this parameter. The role played by interleukin-4 (IL-4) in this model was analysed in vivo by the administration of the 11B11 anti-IL-4 rat MoAb (total dose 36 mg) during the first 12 days following induction of stimulatory GVHR by 8 x 10(7) DBA/2 spleen cells. This treatment completely prevented the development of hyper IgE whereas the administration of a control rat MoAb had no significant effect. We conclude that stimulatory GVHR in mice is associated with a major increase in serum IgE which is mediated by IL-4.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671004      PMCID: PMC1535449          DOI: 10.1111/j.1365-2249.1991.tb05602.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Lymphoid cell surface interaction structures detected using cytolysis-inhibiting monoclonal antibodies.

Authors:  P Golstein; C Goridis; A M Schmitt-Verhulst; B Hayot; A Pierres; A van Agthoven; Y Kaufmann; Z Eshhar; M Pierres
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

2.  A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE.

Authors:  E Gleichmann; E H Van Elven; J P Van der Veen
Journal:  Eur J Immunol       Date:  1982-02       Impact factor: 5.532

Review 3.  Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.

Authors:  D P Dialynas; D B Wilde; P Marrack; A Pierres; K A Wall; W Havran; G Otten; M R Loken; M Pierres; J Kappler
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

4.  Induction of IgE synthesis and potentiation of anti-ovalbumin IgE antibody response by HgCl2 in the rat.

Authors:  A Prouvost-Danon; A Abadie; C Sapin; H Bazin; P Druet
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

5.  Regulation of human immunoglobulin E synthesis in acute graft versus host disease.

Authors:  J A Saryan; J Rappeport; D Y Leung; R Parkman; R S Geha
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

6.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

7.  Increased serum immunoglobulin E levels following allogeneic bone marrow transplantation.

Authors:  R S Geha; J M Rappaport; F J Twarog; R Parkman; F S Rosen
Journal:  J Allergy Clin Immunol       Date:  1980-07       Impact factor: 10.793

8.  Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.

Authors:  A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

9.  Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.

Authors:  A G Rolink; S T Pals; E Gleichmann
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E.

Authors:  F M van Rappard-van der Veen; A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Induction of T helper cell subsets.

Authors:  M Röcken; K M Müller; C Hauser
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

Review 3.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

Review 4.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis.

Authors:  G Shankar; D A Cohen
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

6.  CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody.

Authors:  Alistair Noble; Jamie A Leggat; Else M Inderberg
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

Review 7.  Mast cells and immunological skin diseases.

Authors:  Daniel Navi; Jun Saegusa; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

8.  A role for IL-4 in immunologically mediated enteropathy.

Authors:  A M Mowat; M B Widmer
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

9.  Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.

Authors:  S Takahashi; L Fossati; M Iwamoto; R Merino; R Motta; T Kobayakawa; S Izui
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

10.  Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.

Authors:  A Nagler; V Segal; S Slavin; F Levi-Schaffer
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.